Jon Cuthbert

Quantoz Payments has become a principal member of Visa, enabling it to issue stablecoin-linked virtual debit cards and sponsor fintech partners across Europe.

SGH (ASX:SGH) and US-based Steel Dynamics have launched a revised, all-cash "best and final" takeover bid for BlueScope Steel (ASX:BSL).

National Australia Bank (ASX:NAB) has kicked off FY26 with reporting an unaudited statutory net profit of $2.21 billion for the first quarter.

Builders FirstSource (NYSE:BLDR) reported a significant decline in fourth-quarter profitability, as the nation's largest supplier of structural building products grappled with a "below-normal" environment for new residential housing starts and persistent commodity deflation.

BMC Minerals (ASX:BMC) has commenced its 2026 resource drilling program at the Kudz Ze Kayah Project.

Clinical dermatology leader Botanix Pharmaceuticals (ASX:BOT) has secured firm commitments to raise approximately $45 million in new capital.

Gourmet food giant Maggie Beer (ASX:MBH) is considering offloading its online hampers and gifts division.

The Reserve Bank of Australia signaled a shift toward heightened vigilance, opting to raise the cash rate by 25 basis points.

Medtronic (NYSE:MDT) reported third-quarter fiscal 2026 revenue of $9.017 billion, an increase of 8.7% as reported and 6.0% on an organic basis, surpassing the midpoint of its guidance by 50 basis points and marking the highest enterprise revenue growth in the past 10 quarters.

Harmony Biosciences Holdings (NASDAQ:HRMY) announced Tuesday that the U.S. Food and Drug Administration (FDA) has approved its supplemental New Drug Application (sNDA) for WAKIX® (pitolisant) to treat cataplexy in pediatric patients aged six years and older.